New Key Statistics Module, Z-Score and F-Score
NAS:OCUL Key Ratios
| Market Cap $ M | 876.67 |
| Enterprise Value $ M | 792.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.14 |
| Price/Sales | 9.06 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 59.00 |
| EPS (TTM) $ | -1.35 |
| Beneish M-Score | -2.48 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.41 |
| EV-to-EBITDA | -11.93 |
| PEG | -- |
| Shares Outstanding M | 154.89 |
| Net Margin (%) | -192.62 |
| Operating Margin % | -152.82 |
| Pre-tax Margin (%) | -192.62 |
| Quick Ratio | 21.29 |
| Current Ratio | 21.39 |
| ROA % (ttm) | -47.85 |
| ROE % (ttm) | -110.88 |
| ROIC % (ttm) | -347.57 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.76 |
OCUL Number of Guru Trades
OCUL Volume of Guru Trades
Gurus Latest Trades with NAS:OCUL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OCUL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ocular Therapeutix Inc Insider Transactions
No Available Data
News about NAS:OCUL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers